In 2011, the United States and Canada came together to create the US-Canada Regulatory Cooperation Council (RCC) in order to reduce economic barriers and increase regulatory support between the two countries.
Four years later, Health Canada and FDA are making efforts to continue to harmonize how both countries regulate drugs, medical devices and biological products. The two agencies are currently working on plans to synchronize the three disciplines and have already completed one plan (See their most recent plan). The two partnering countries hope their efforts increase commerce between the US and Canada, as well as improve the health care industry.
Click here to read more on the background of Health Canada and its future efforts. Need help with a Canadian regulatory filing? We can help. Contact us at contact@pearlpathways.com .